Investing.com - Ossur reported on Friday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Ossur announced earnings per share of $0.03 on revenue of $181M. Analysts polled by Investing.com anticipated EPS of $0.0308 on revenue of $192.47M.
Ossur shares are down 31% from the beginning of the year and are trading at $30.45 , down-from-52-week-high.They are under-performing the STOXX 600 which is down 13.83% from the start of the year.
Ossur follows other major Healthcare sector earnings this month
Ossur's report follows an earnings beat by Coloplast on Wednesday, August 17, 2022, who reported EPS of $6.14 on revenue of $5.85B, compared to forecasts EPS of $5.92 on revenue of $5.74B.
Demant had beat expectations on Monday, August 15, 2022 with second quarter EPS of $5.04 on revenue of $4.89B, compared to forecast for EPS of $4.91 on revenue of $5.02B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar